The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
ArticleNo Access

TREATMENT OF HYPERKINETIC EMOTIONALLY DISTURBED CHILDREN WITH PROLONGED ADMINISTRATION OF CHLORPROMAZINE

Published Online:https://doi.org/10.1176/ajp.113.1.22

Twenty-five hyperkinetic, emotionally disturbed children were treated with chlorpromazine for periods lasting from 4 to 16 months. They also served as their own controls by receiving placebo medication for 4 to 6 weeks during some phase of treatment. Response was determined from the following observations: (1) Clinical changes noted by the clinic staff which included the social worker and psychologist as well as the therapist; (2) data from the home environment; (3) reports from the school counselors; (4) changes in the battery of psychological tests done before and after treatment.

Improvement in varying degrees was noted in 21 cases—84%, and was marked in 70%. Diminution in hyperactivity was the outstanding phenomenon. Combativeness was reduced considerably. There was definite improvement in willingness to learn.

The psychological testing suggested that the learning process was facilitated. Trends toward increased emotional control were evidenced although the basic personality seemed unchanged.

The procedure was effective because an "improved interpersonal relationship" could be established and exploited for the sake of the learning process.

The side effects were minimal compared with those of adults and did not necessitate the termination of treatment in any case. Sequential blood count studies were negative.

It is suggested that, perhaps for the first time, we have a drug which dampens the primitive fight-flight responses, possibly actuated by the "arousal system" of Magoun (15). It is further suggested that by controlling this basic mechanism without impairing consciousness and the learning process, we can now do more effective psychotherapy.

We seem to have entered the era of "combined therapy" where drug therapy and psychotherapy are complementary and can be combined to change the personality most effectively.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.